Clean Sweep Live Auction on Wed. May 1st. Click to view the full inventory

DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Pediatrics
Current Location:
> This Story

Log in or Register to rate this News Story
Forward Printable StoryPrint Comment




European News Homepage

This UK company is utilizing space technology to develop a portable 3D X-ray system Adaptix has received $1.35 million from space agencies

Industrial hi-res X-ray yields greater insight into child abuse case Identified microscopic injuries that would not have been detected with standard CT

Siemens and ESR present first Digital Experience Hall at ECR Aims to stimulate exchange of thoughts and knowledge about digitization in radiology

Varex Imaging and H+P Advanced Technology to build carbon nanotube company Expect to see products come out in two-to-three years

Data sharing for imaging trials low, says ESR research committee at ECR Interest is high but concerns remain

Varex Imaging expands service offering to Europe, releases new tube and detector line at ECR Provide technical and logistical support for installations

Hitachi unveils new CT and ultrasound solutions at ECR Standard version of SCENARIA VIEW and three new Arietta ultrasound solutions

Age of imaging equipment in Europe is a cause of increasing concern About 20 percent of installed base is over a decade old: COCIR

My one day at ECR: Michael Friebe Dr. Friebe shares his candid insights on the big event

Siemens unveils Artis icono biplane angio system at ECR Enables diagnostics and treatment to take place in same lab, improved 2D and 3D capabilities

Europe needs greater investment in radiation therapy to meet growing demand: ESTRO

by John W. Mitchell , Senior Correspondent
As cancer rates increase globally, researchers have illustrated an unmet demand for radiation therapy access across Europe — and are calling for increased investment in the treatment, updated technology, and workforce training.

“There is a gap between the need for radiotherapy (radiation therapy), based on evidence, and the actual radiotherapy utilization,” Josep M. Borras, M.D., Ph.D. at the University of Barcelona, Spain and co-author of the study, told HCB News. “The present paper suggests that this situation will be worsened in the near future unless governments and health care decision-makers undertake clear and decisive actions.”

Story Continues Below Advertisement

Servicing GE Nuclear Medicine equipment with OEM trained engineers

We offer full service contracts, PM contracts, rapid response, time and material,camera relocation. Nuclear medicine equipment service provider since 1975. Click or call now for more information 800 96 NUMED

The European Society for Radiotherapy and Oncology (ESTRO) conducted the study, which was just published in the journal Radiotherapy and Oncology. The findings will also be presented later this month at its annual conference, in Turin, Italy.

A senior panel of radiation oncologists and epidemiologists conducted the study. They found that overall the number of European patients who would benefit from radiotherapy treatment at least once during the course of their disease would rise 16.1 percent by 2025.

The detailed estimates for many different tumor sites produced some major increases. In breast, rectum, head and neck, lung, and prostate tumors, which account for the highest percentage of patients in a radiotherapy department, there were relative increases of more than 25% in rectal patients for whom radiotherapy would be indicated in Spain, The Netherlands, and the Czech Republic; while Belgium, the U.K., and Denmark had estimated increases of more than 20%.

Almost all the Eastern European countries - with the exception of Poland, Slovakia and the Czech Republic - showed the lowest increase of new cancer cases. The highest increases were projected in the Netherlands, Ireland and Switzerland.

Borras also said the study is significant because it used statistical modeling to put a reliable number on a widely held premise that cancer rates are on the rise worldwide.

“Planning for the future needs of radiotherapy infrastructure and staff is possible based on solid epidemiological data and projections of cancer cases, combined with the assessment of the evidence-based indications of radiotherapy,” Borras said. He added that the study team was not expecting the need in the next ten years to be so substantial.

The ESTRO findings reflect cancer trends stated in other studies. A 2009 U.S. study in the Journal of Clinical Oncology projected cancer rates would increase by 30 percent in the U.S. by 2030. A 2015 World Health Organization projection estimated worldwide cancer rates will increase by 70 percent over the next two decades.

According to Borras, radiation therapy is one of the “main pillars” for clinically- and cost-effective treatment of multidisciplinary cancer.

“The findings of this (ESTRO) study could be useful for cancer control plans, governments and national societies to properly forecast the needs for investment in radiotherapy facilities and staff in the mid-term,” said Borras.

European News Homepage

You Must Be Logged In To Post A Comment

Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Gold Service Dealer Program
Receive RFP/PS
Healthcare Providers
See all
HCP Tools
A Job
Parts Hunter +EasyPay
Get Parts
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2019 DOTmed.com, Inc.